Kloxxado™ (naloxone) – New drug approval
April 30, 2021 - The FDA announced the approval of Hikma Pharmaceuticals’ Kloxxado (naloxone), for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients.
Top